A sixty-two-year-old man who underwent coronary angiography and received acute thrombolytic and anticoagulant therapy for acute myocardial infarction developed multisystemic injury, including renal insufficiency and cutaneous manifestations. Fundoscopic examination and skin biopsy specimen led to the diagnosis of multiple cholesterol embolization syndrome (MCES). Discontinuation of anticoagulants and administration of hemostatic (carbazochrome, tranexamic acid, reptilase, and vitamin K) and antihyperlipidemic (cholestyramine and probucol) drugs resulted in temporary improvement of cutaneous and renal disorders and extended survival for about one year. Besides severe aortic atherosclerosis, postmortem examination revealed numerous cholesterol emboli to multiple organs. MCES is a rare but serious complication of left heart catheterization and anticoagulant therapy, and the optimal treatment remains to be established. The authors suggest here that the above-mentioned therapy might be effective for management of MCES.
Get full access to this article
View all access options for this article.
References
1.
Drost H., Buis B., Haan D., et al: Cholesterol embolism as a complication of left heart catheterization . Br Heart J52:339-342, 1984.
2.
Beal MF, Williams RS, Richardson EP Jr, et al: Cholesterol embolism as a cause of transient ischemic attacks and cerebral infarction. Neurology31:860-865, 1981.
3.
Fisher ER, Hellstrome HR, Myers JD: Disseminated atheromatous emboli. Am J Med28:176-180, 1960.
4.
Kalter DC, Rudolph A., McGavran M.: Livedo reticularis due to multiple cholesterol emboli. J Am Acad Dermatol13:235-242, 1985.
5.
Zatuchin J., Patel HK, Chiemchanya S.: The "blue toe" syndrome with renal atheroembolism and failure. Angiology36:209-214, 1985.
6.
Rosansky SJ: Multiple cholesterol emboli syndrome. South Med J75:677-680, 1982.
7.
Fine MJ, Kapoor W., Falanga V.: Cholesterol crystal embolization: A review of 221 cases in the English literature . Angiology38:769-784, 1987.
8.
Rosansky SJ, Deschamps EG: Multiple cholesterol emboli syndrome after angiography. Am J Med Sci288:45-48, 1984.
9.
Bruns FJ, Segel DP, Adler S.: Control of cholesterol embolization by discontinuation of anticoagulant therapy . Am J Med Sci275:105-108, 1978.
10.
Hyman BT, Landas SK, Ashman RF, et al: Warfarin-related purple toes syndrome and cholesterol microembolization . Am J Med82:1233-1237, 1987 .
11.
Fisher DF Jr, Clagett GP, Brigham RA, et al: Dilemmas in dealing with the blue toe syndrome: Aortic versus peripheral source. Am J Surg148:836-839, 1984.
12.
Robicsek F. : Prevention of cholesterol embolism (trash foot) during aorto-iliac reconstruction using a blood filtering device. J Cardiovasc Surg27:63-64, 1986.
13.
Schwartz MW , McDonald GB: Cholesterol embolization syndrome. Occurrence after intravenous streptokinase therapy for myocardial infarction . JAMA258:1934-1935, 1987 .
14.
Siemons L., Heuvel PV, Parizel G., et al: Peritoneal dialysis in acute renal failure due to cholesterol embolization: Two cases of recovery of renal function and extended survival . Clin Nephrol28:205-208, 1987.
15.
Shefer S., Cheng FW, Hauser S., et al: Regulation of bile acid synthesis. Measurement of cholesteral 7α-hydroxylase activity in rat liver microsomal preparations in the absence of endogenous cholesterol. J Lipid Res22:532-536, 1981.
16.
Wissler RW, Vesselinovitch D.: Combined effects of cholestyramine and probucol on regression of atherosclerosis in rhesus monkey aortas. Appl Pathol1:89-96, 1983.
